3.8 Article

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

Publisher

WILEY
DOI: 10.1016/j.trci.2019.09.005

Keywords

Biomarkers; Neuroimaging; Alzheimer's disease; Frontontemporal dementia; Dementia with Lewy bodies; Neurodegeneration

Funding

  1. CIBERNED
  2. Instituto de Salud Carlos III
  3. Fondo Europeo de Desarrollo Regional (FEDER), Union Europea, Una manera de hacer Europa
  4. Generalitat de Catalunya
  5. Fundacio La Marato TV3 Fundacio Bancaria Obra Social La Caixa
  6. Fundacion BBVA
  7. Fundacion Espanola para el Fomento de la Investigacion de la Esclerosis Lateral Amiotrofica (FUNDELA)
  8. Global Brain Health Institute
  9. Fundacio Catalana Sindrome de Down
  10. Fundacio Victor Grifols i Lucas

Ask authors/readers for more resources

Introduction: The SPIN (Sant Pau Initiative on Neurodegeneration) cohort is a multimodal biomarker platform designed for neurodegenerative disease research following an integrative approach. Methods: Participants of the SPIN cohort provide informed consent to donate blood and cerebrospinal fluid samples, receive detailed neurological and neuropsychological evaluations, and undergo a structural 3T brain MRI scan. A subsetalso undergoes other functional or imaging studies (video-polysomnogram, F-18-fluorodeoxyglucose PET, amyloid PET, Tau PET). Participants are followed annually for a minimum of 4years, with repeated cerebrospinal fluid collection and imaging studies performed every other year, and brain donation is encouraged. Results: The integration of clinical, neuropsychological, genetic, biochemical, imaging, and neuropathological information and the harmonization of protocols under the same umbrella allows the discovery and validation of key biomarkers across several neurodegenerative diseases. Discussion: We describe our particular 10-year experience and how different research projects were unified under an umbrella biomarker program, which might be of help to other research teams pursuing similar approaches. (C) 2019 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer's Association.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available